The Ability of Vaping Technology to Deliver an Equivalent Respirable Dose of Beclomethasone Dipropionate Compared to Nebulization

The Ability of Vaping Technology to Deliver an Equivalent Respirable Dose of Beclomethasone Dipropionate Compared to Nebulization

<b>Background/Objectives</b>: This study focuses on the ability of vaping technology to deliver beclomethasone dipropionate compared to nebulization. <b>Methods</b>: An in vitro comparison of aerosol properties in terms of respirable dose with the Glass Twin Impinger and the...

Full description

Saved in:
Bibliographic Details
Main Authors: Cyrille Bruneau, Clément Mercier, Lara Leclerc, Jérémie Pourchez
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Pharmaceutics
Subjects:
vaping drug delivery system
jet nebulizer
respirable dose
aerosol therapy
chronic respiratory diseases
beclomethasone dipropionate
Online Access:https://www.mdpi.com/1999-4923/16/11/1396
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1999-4923/16/11/1396

Similar Items